Long-acting contraceptives. Rationale, current development, and ethical implications.
Brown
G F
GF
The Population Council, New York, N.Y., USA.
D035843:Biomedical Research; D003267:Contraception; D003271:Contraceptive Agents, Female / Q000008:administration & dosage / Q000266:history; D003692:Delayed-Action Preparations; D003906:Developing Countries; D004343:Drug Implants; D026724:Ethical Review; D004992:Ethics, Medical; D005260:Female; D049673:History, 20th Century; D006801:Humans; D007267:Injections; D038622:Internationality; D007434:Intrauterine Devices / Q000266:history; D008297:Male; D015735:Mifepristone / Q000627:therapeutic use; D010358:Patient Participation; D012106:Research; D040841:Resource Allocation; D018570:Risk Assessment; D012749:Sexually Transmitted Diseases / Q000517:prevention & control; D014612:Vaccines
D003271:Contraceptive Agents, Female; D003692:Delayed-Action Preparations; D004343:Drug Implants; D014612:Vaccines; D015735:Mifepristone